Vaccination and autoimmunity - 'Vaccinosis': A dangerous liaison?

Journal of Autoimmunity

Volumn 14, Issue 1, 2000, Pages 1-10

  Shoenfeld, Y ^a   Aron Maor, A ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Autism; Autoantibodies; Autoimmunity; Guillain Barre syndrome; Hepatitis; Measles; Multiple sclerosis; Rheumatoid arthritis; SLE; Vaccine

Indexed keywords

AUTOANTIBODY; BCG VACCINE; DIPHTHERIA VACCINE; HEPATITIS B VACCINE; HEPATITIS C VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; MUMPS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; RUBELLA VACCINE; SMALLPOX VACCINE; TETANUS TOXOID; TYPHOID VACCINE; VACCINE;

AUTISM; AUTOIMMUNE DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DOG; GUILLAIN BARRE SYNDROME; HEPATITIS B; MEASLES; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RISK; VACCINATION;

EID: 0033973446     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1999.0346     Document Type: Article

References (97)

1. Cohen A.D., Shoenfeld Y. Vaccine-induced autoimmunity. J. Autoimmune. 9:1996;699-703.
2. Stratton K.R., Howe C.J., Johnston R.B. Adverse events associated with childhood vaccines other than pertussis and rubella. JAMA. 271:1994;1602-1605.
3. Ropper A.H. The Guillain-Barre syndrome. New Engl. J. Med. 326:1992;1130-1136.
4. Rostami A.M. Pathogenesis of immune-mediated neuropathies. Pediatr. Res. 33:1993;590-594.
5. Fredman P., Vedeler C.A., Nyland H., Aarli J.A., Svennerholm L. Antibodies in sera from patients wih inflammatory demyelinating polyradiculoneuropathy reactive with ganglioside LM1 and sulfatide of peripheral nerve myelin. J. Neurol. 238:1991;75-79.
6. Melnick S.C. Role of infection in the Guillain-Barre syndrome. Neurol. Neurosurg. Psychiatry. 27:1964;395-407.
7. Pepose J.S. A theory of virus-induced demyelination in the Landry-Guillain-Barre syndrome. J. Neurol. 227:1982;93-97.
8. Dowling P.C., Cook S.D. Role of infection in Guillain-Barre syndrome: laboratory confirmation of herpes virus in 41 cases. Ann. Neurol. 9:1981;44-55.
9. Van Doorn P.A., Brand A., Vermeulen N. Anti-neuroblastoma cell-line antibodies in inflammatory demyelinating polyneuropathy: inhibition in vitro by intravenous immunoglobulins. Neurology. 38:1988;1592-1595.
10. Schmitz H., Enders G. Cytomegalovirus as a frequent cause of Guillain-Barre syndrome. J. Med. Virol. 1:1977;21-27.
11. Grose C., Spizland I. Guillain-Barre syndrome following administration of live measles vaccine. Am. J. Med. 60:1976;441-443.
12. Gruenewald R., Ropper A.H., Lior H., Chan J., Lee R., Molinaro V.S. Serologic evidence of Campylobacter Jejuni and E. coli enteritis in patients with Guillain-Barre syndrome. Arch. Neurol. 48:1991;1080-1082.
13. Terryberry J., Sutjita M., Shoenfeld Y., Gilburd B., Tanne D., Lorber M., Alosachie I., Barka N., Lin H.C., Youinou P. Myelin- and microbe-specific antibodies in Guillian-Barre syndrome. J. Clin. Lab. Analysis. 9:1995;308-319.
14. Abu-Shakra M., Shoenfeld Y. Shoenfeld Y., Isenberg D. Natural autoantibodies. 1993;15-33 CRC Press, Boca-Raton.
15. Koski C.L. Humoral mechanisms in imune neuropathies. Neurol. Clin. 10:1992;629-649.
16. Ropper A.H., Victor M. Influenza vaccination and the Guillain-Barre syndrome. New Engl. J. Med. 339:1998;1845-1846.
17. Lasky T., Terracciano G.J., Magder L., Koski C.L., Ballesteros M., Nash D., Clark S., Haber P., Stolley P.D., Schonberger L.B., Chen R.T. The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines. New Engl. J. Med. 339:1998;1797-1801.
18. Langmuir A.D., Bregman D.J., Kurland L.T., Nathanson N., Victor M. An epidemiologic and clinical evaluation of Guillain-Barre syndrome reported in association with the administration of swine influenza vaccines. Am. J. Epidemiol. 79:1984;841-879.
19. Hugghes R.A., Chondhary P.P., Osborn M., Rees J.H., Sanders E.A. Immunization and risk of relapse of Guillain-Barre syndrome or chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 19:1996;1230-1231.
20. Genain C.P., Cannella B., Hauser S.L., Raine C.S. Identification of autoanibodies associated with myelin damage in multiple sclerosis. Nature Med. 5:1999;170-175.
21. Marshall E. A shadow falls on Hepatitis B vaccination effort. Science. 281:1998;630-631.
22. Herroelen L., de Keyser J., Ebinger G. Central nervous system demyelination after immunization with recombinant Hepatitis B vaccine. Lancet. 338:1991;1174-1175.
23. Nadler J.P. Multiple sclerosis and Hepatitis B vaccination. Clin. Infect. Dis. 17:1993;928-929.
24. Alter M. Is multiple sclerosis an age-dependent host response to measles? Lancet. 28:1976;456-457.
25. Currier R.R.D. Measles vaccination has had no effect on the occurrence of multiple sclerosis. Arch. Neurol. 53:1996;1216.
26. Riikonen R. The role of infection and vaccination in the genesis of optic neuritis and multiple sclerosis in children. Acta. Neurol. Scand. 80:1989;425-431.
27. Hull T.P., Bates J.H. Optic neuritis after influenza vaccination. Am. J. Ophthalmol. 124:1997;703-704.
28. Weizman A., Weizman R., Szekely G.A., Wijsenbeek H., Livni E. Abnormal immune response to brain tissue antigen in the syndrome of autism. Am. J. Psychiat. 7:1982;1462-1465.
29. Singh V.K., Warren R.P., Odell J.D., Warren W.L., Cole P. Antibodies to myelin basic protein in children with autistic behaviour. Brain Behav. Immun. 7:1993;97-103.
30. Singh V.K., Sheren X.L., Yang V.C. Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clin. Immunol. Immunopathol. 89:1998;105-108.
31. Lee J.W., Melgaard B., Clementa C.J. Autism, inflammatory bowel disease and MMR vaccine. Lancet. 351:1998;905-909.
32. Gupta S., Aggarnal S., Heads C. Brief report: Dysregulated immune system in children with autism: beneficial effects of intravenous immunoglobulins on autistic characteristics. J. Autism. Develop. Dis. 26:1996;439-450.
33. Peltola H., Patja A., Leinikki P., Valle M., Davidkin I., Paunio M. No evidence for measles, mumps and rubella vaccine-associated inflammatory bowel disease or autism in a 14 year prospective study. Lancet. 351:1998;1327-1328.
34. Taylor B., Miller E., Farrington C.P., Petropoulos M.C., Favot-Mayaud I., Li J., Waight P.A. Autism and measles, mumps and rubella vaccine: no epidemiological evidence for a causal association. Lancet. 353:1999;2026-2029.
35. Brodsky L., Stanievich J. Sensorineural hearing loss following live measles vaccination. Int. J. Pediatric. Otolaryngol. 16:1998;159-163.
36. Stewart B.J.A., Prabhu P.U. Reports of sensorineural hearing loss after measles, mumps and rubella immunization. Arch. Dis. Childhood. 69:1993;153-154.
37. Paira S.O. Sudden sensory-neural hearing loss in patients with systemic lups erythematosus or lupus-like syndrome and antiphospholipid antibodies. J. Rheumatol. 25:1998;2476-2477.
38. Brey R.L. Neurological manifestations of antiphospholipid antibody syndrome. Lupus. 7:1998;S67-74.
39. Naarendorp M. Sudden sensoryneural hearing loss in patients with systemic lupus erythematosus or lupus-like syndromes and antiphospholipid antibodies. J. Rheumatol. 25:1998;589-592.
40. Plesner A.M. Gait disturbances after measles, mumps and rubella vaccine. Lancet. 345:1995;316.
41. Grasland A., Vinceneux P. Rheumatic manifestations of vaccination. Rheumat. Eur. 28:1999;25-27.
42. Benjamin C.M., Chew C.G., Silman A.J. Joint and limb symptoms in children after immunization with measles, mumps and rubella vaccine. BMJ. 304:1992;1075-1077.
43. Symmons D.P.M., Chakravarty K. Can immunization trigger rheumatoid arthritis. Ann. Rheum. Dis. 52:1993;843-844.
44. Aho K., Kottinen A., Rajasalmi M., Werger O. Transient appearance of rheumatoid factor in connection with profilactic vaccinations. Acta. Path. Microbiol. Scand. 56:1962;478-479.
45. Peeler R.N., Kadull P.J., Cluff L.E. Intensive immunization of man: evaluation of possible adverse consequences. An. Intern. Med. 63:1956;44-57.
46. Robertson P.W., Leonard B.J. Some delayed complications of inoculation. BMJ. 2:1956;1029-1032.
47. Kurland L.T., Molgaard C.A., Kurland E.M., Erdtman F.J., Stebbing G.E.T. Lack of association of swine flu vaccine and rheumatoid arthritis. May. Clin. Proc. 59:1984;816-821.
48. Gross K., Combe C., Kruger K., Schattenkkirschner M. Arthritis after hepatitis B vaccination. Scand. J. Rhematol. 24:1995;50-52.
49. Pope J.E., Stevens A., Howson W., Bell D.A. The development of rheumatoid arthritis after recombinant hepatitis B vaccine. J. Rheumatol. 25:1998;1687-1693.
50. Tischler M., Shoenfeld Y. Tuberculose et immunite: ou en sommes-nous? Ann. Inst. Pasteur. 7:1996;133-136.
51. Belmatong E., Levy-Ojebbour, Appelboom T., De Gennes C., Peltier A.P., Meyer O., Kahn M.F., Carbon C. Polyarthritis in four patients treated with intravesical BCG for bladder carcinoma. Rev. Rhum. 60:1993;130-131.
52. James J.A., Kaufman K.M., Farris A.D., Taylor-Albert E., Lehman T.J., Harley J.B. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J. Clin. Invest. 100:1997;3019-3026.
53. Vaughan J.H. The Epstein-Barr virus and systemic lupus erythematosus. J. Clin. Invest. 100:1997;2939-2940.
54. Dror Y., Blachar Y., Cohen P., Livni N., Rosenmann E., Ashkenazi A. Systemic lupus erythematosus associated with acute Epstein-Barr virus infection. Am. J. Kidney Dis. 32:1998;825-828.
55. Incaprera M., Rindi L., Bazzichi A., Garzelli C. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity. Clin. Exp. Rheumatol. 16:1998;289-294.
56. Dostal C., Newkirk M.M., Duffy K.N., Paleckova A., Bosak V., Cerna M., Zd'arsky E., Zvarova J. Herpes viruses in multicase families with rheumatoid arthritis and systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 815:1997;334-337.
57. Keen G.A., Yeats J. Epstein-Barr virus-induced systemic lupus erythematosus. S. Afr. Med. J. 86:1996;850.
58. Matsukawa Y. Epstein-Barr virus-induced systemic lupus erythematosus. S. Afr. Med. J. 86:1996;850-851.
59. Tudela P., Marti S., Bonal J. Systemic lupus erythematosus and vaccination against hepatitis B. Nephron. 62:1992;236.
60. Finielz P., Lam-Kam-Sang L.F., Guiserix J. Systemic lupus erythematosus and thrombocytopenic purpura in two members of the same family following hepatitis B vaccine. Nephrol. Dial. Transplant. 13:1998;2420-2421.
61. Tudela P., Marti S., Bonal J. Systemic lupus erythematosus and vaccination against hepatitis B. Nephron. 62:1992;236.
62. Guiserix J. Systemic lupus erythematosus following Hepatitis B vaccine. Nephron. 74:1996;441.
63. Mamoux V., Dumont C. Lupus erythemateux dissemine et vaccination contre l'hepatite B. Arch. Pediatr. 1:1994;307-308.
64. Grezard P., Chafi M., Philippot V., Perrot H., Faisant M. Cutaneous lupus erythematosus and buccal aphthosis after hepatitis B vaccination in a 6-year-old child. Ann. Dermatol. Venereol. 123:1996;657-659.
65. Ramirez O., Ramirez R. Lupoid syndrome in BCG-itis. Report of a case. Med. Cutano Ibero Lat. Am. 14:1986;87-89.
66. Stewart W.M., Lecroq C., Damon B. Lupus after BCG vaccination: three familial cases. Bull. Soc. Er. Dermatol. Syphilis. 75:1968;846-848.
67. Misery L., Combemale P. Systemic urticaria disclosing post-vaccine lupus tuberculosis. Ann. Dermatol. Venereal. 120:1993;233-235.
68. Rodrigues A., Coelho R.D., Pereira F. Lupus vulgaris after BCG vaccine; A clinical case. Med. Cutan. Ibero. Lt. Am. 18:1990;224-226.
69. Izumi A.K., Matsunaga J. BCG vaccine-induced lupus vulgaris. Arch. Dermatol. 118:1982;171-172.
70. Baxter A.G., Horsfall A.C., Healey D., Ozegbe P., Day S., Williams D.G., Cooke A. Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology. 83:1994;227-231.
71. Karopoulos C., Rowley M.J., Handley C.J., Strugnell R.A. Antibody reactivity to mycobacterial 65 kDa heat shock protein: relevance to autoimmunity. J. Autoimmun. 8:1995;235-248.
72. Feige U., van Eden W. Infection, autoimmunity and autoimmune disease. EXS. 77:1996;359-373.
73. Classen D.C., Classen J.B. The timing of pediatric immunization and the risk of insulin-dependent diabetes mellitus. Infect. Dis. Clin. Pract. 6:1997;449-454.
74. Classen J.B., Classen D.C. Public should be told that vaccines may have long-term adverse effects. BMJ. 318:1999;193.
75. Blom L., Nystrom L., Dahlquist G. The Swedish childhood diabetes study. Vaccinations and infection as risk determinants for diabetes in childhood. Diabetologica. 34:1991;176-181.
76. Karvonen M., Zygimantas C., Tuomilehto J. Association between type 1 diabetes and Haemophilus influenzae type b vaccination: birth cohort study. BMJ. 318:1999;1169-1172.
77. Pediatr. Infect. Dis. J. 18:1999;217-222.
78. Joekes A.M., Gabriel J.R.T., Goggin J. Renal disease following prophilactic inoculation. Nephron. 9:1972;162-170.
79. Freud P., Maffia A.J., Hosbach R.E., Valicenti P.W. Smallpox vaccination followed by acute renal failure. Amer. J. Dis. Child. 99:1960;98-100.
80. Stefanini M., Piomelli S., Ostrovski J.F., Colpoys W.P. Acute vascular purpura following immunization with asiatic influenza vaccine. New Engl. J. Med. 259:1958;9-12.
81. Bishop W.B., Carlton R.F., Fanders L.L. Diffuse vaculitis and death after hyperimmunization with pertussis vaccine. Report of a case. New Engl. J. Med. 274:1966;661-669.
82. Le Hello C., Cohen P., Bousser M.G., Letellier P. Suspected hepatitis B vaccination related vasculitis. J. Rheumatol. 26:1999;191-192.
83. Bamford C.R., Sibley W.A., Laguna J.F. Swine influenza vaccination in patients with multiple sclerosis. Arch. Neurol. 35:1978;242-243.
84. Kurland L.T., Molgaard C.A., Kurland E.M., Wiederholt W.C., Kirkpatrick J.W. Swine flu vaccine and multiple sclerosis. JAMA. 251:1984;2672-2675.
85. Sibley W.A., Bamford C.R., Laguna J.F. Influenza vaccination in patients with multiple sclerosis. JAMA. 236:1976;1965-1966.
86. Salvetti M., Pisani A., Bastianello S., Millefiorini E., Buttinelli C., Pozzilli C. Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination. J. Neurol. 242:1995;143-146.
87. Miller A.E., Morgante L.A., Buchwald L.Y., Nutile S.M., Coyle P.K., Krupp L.B., Doscher C.A., Lublin F.D., Knobler R.L., Trantas F., Kelley L., Smith C.R., La Rocca N., Lopez S. A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology. 48:1997;312-314.
88. Brodman R., Gilfillan R., Glass D., Schur P.H. Influenzal vaccine response in systemic lupus erythematosus. Ann. Intern. Med. 88:1978;735-740.
89. Williams G.W., Steinberg A.D., Reinertsen J.L., Klassen L.W., Decker J.L., Dolin R. Influenza immunization in systemic lupus erythematosus. A double-blind trial. Ann. Intern. Med. 88:1978;729-734.
90. Ristow S.C., Douglas R.G., Condemi J.J. Influenza vaccination of patients with systemic lupus erythematosus. Ann. Intern. Med. 88:1978;786-789.
91. Cimmino M.A., Seriolo B., Accardo S. Influenza vaccination in rheumatoid arthritis. J. Rheumatol. 22:1995;1802.
92. Heron A., Dettleff G., Hixon B., Brandwin L., Ortbals D., Hornick R., Hahn B. Influenza vaccination in patients with rheumatic diseases. Safety and efficacy. JAMA. 242:1979;53-56.
93. Dickman S. Possible cause found for lyme arthritis. Science. 281:1998;631.
94. Zandman-Goddard G., Blank M., Ehrenfeld M., Gilburd B., Peter J., Shoenfeld Y. A comparison of autoantibody production in asymptomatic and symptomatic women with silicone breast implants. J. Rheumatol. 1:1999;73-77.
95. Hogenesch H., Azcona-Olivera J., Scott-Montcrieff C., Snyder P.W., Glickman L.T. Vaccine-induced autoimmunity in the dog. Adv. Vet. Med. 41:1999;733-747.
96. Murphy-Ullrich J.E., Oberley T.D., Mosher D.F. Detection of autoantibodies and glomerular injury in rabbits immunized with denatured human fibronectin monomer. Am. J. Pathol. 117:1984;1-11.
97. Abrahamson D.R., Caulfield J.P. Proteinuria and structural alterations in rat glomerular basement membranes induced by intravenously injected anti-laminin immunoglobulin G. J. Exp. Med. 156:1982;128-145.